Alberto Cambrosio


alberto.cambrosio [at] | 514 398-4981 | 3647 Peel, room 202

Initially trained as a biologist in Switzerland, I completed a Ph.D. in History and Socio-Politics of Science at the University of Montreal, and a post-doc at MIT’s Science, Technology & Society Program. A member of McGill’s Department of Social Studies of Medicine since 1990, I chaired the department from 2005 to 2016. I have been an invited researcher/visiting professor at several foreign institutions, including the University of Edinburgh, Sciences Po (Paris), Mines Paris-Tech, the Max-Planck Institute for the History of Science (Berlin), and the University of Cardiff. My research has been supported by major Canadian (CIHR, SSHRC, FRQSC, Genome Quebec) and foreign (French Cancer Research Institute) agencies.


Research Interests:

Biomedical science & technology studies. In particular:

  •  Biomedical innovation at the clinical, laboratory, biotechnology, and pharmaceutical industry interfaces.
  •  ‘Genomics in action’: analysis of concrete instances of bio-clinical work, via the investigation of public, academic, and commercial programs that capitalize on the therapeutic insights offered by the new molecular genetics of cancer.
  •  Oncology’s ‘metaknowledge’ networks: deployment of new computational tools to trace research teams and collaboration networks, investigative and clinical technologies, the myriad recombinant elements under investigation, and the changing landscape of institutions that hosts them.

Selected Publications:

Peter Keating and Alberto Cambrosio, Cancer on Trial: Oncology as a New Style of Practice. Chicago: The University of Chicago Press, 2012; xviii, 456 p. Paperback edition: 2014.

Peter Keating and Alberto Cambrosio, Biomedical Platforms. Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine. Cambridge, MA: MIT Press, 2003; xiv, 544 p. Paperback edition: 2006.

Alberto Cambrosio, Pascale Bourret, Peter Keating and Nicole Nelson, “Opening the Regulatory Black Box of Clinical Cancer Research: Transnational Expertise Networks and ‘Disruptive’ Technologies.” Minerva, 55(2) (2017), 161-185.

Peter Keating, Alberto Cambrosio and Nicole Nelson “’Triple Negative Breast Cancer’: Translational Research and the (Re)Assembling of Diseases in Post-Genomic Medicine.” Studies in History and Philosophy of Biological and Biomedical Sciences, 59 (2016), 20-34.

Nicole Nelson, Peter Keating, Alberto Cambrosio, Adriana Aguilar-Mahecha and Mark Basik, “Testing Devices or Experimental Systems? Cancer Clinical Trials Take the Genomic Turn.” Social Science & Medicine, 111 (2014), 74-83.

Nicole Nelson, Peter Keating and Alberto Cambrosio, “On Being ‘Actionable’: Clinical Sequencing and the Emerging Contours of a Regime of Genomic Medicine in Oncology.” New Genetics & Society, 32 (2013), 405-428.

Courses Given:

SOCI 515/HSSM 610: Medicine and Society/The Sociology of Medicine

PDF icon cv_ac.pdf

Stay Connected